Tehran University of Medical Sciences

Science Communicator Platform

Stay connected! Follow us on X network (Twitter):
Share this content! On (X network) By
The Latest Findings of Gamma Irradiation of Blood Products to Prevent Transfusion-Associated Graft-Versus-Host Disease (Ta-Gvhd) in Cancer Patients: A Systematic Review Publisher



Mehrizi TZ1 ; Vodjgani M2 ; Keyvani H1 ; Falak R3 ; Javanmard A4 ; Eshrati B1 ; Shahmabadi HE5 ; Ardestani MS6
Authors
Show Affiliations
Authors Affiliations
  1. 1. Vaccine Research Center, Iran University of Medical Sciences, Tehran, Iran
  2. 2. Department of Immunology, School of Medicine, Tehran University of Medical Sciences, Tehran, Iran
  3. 3. Immunology Research Center, Iran University of Medical Science, Tehran, Iran
  4. 4. Cancer Research Center, Shahid Beheshti University of Medical Sciences, Tehran, Iran
  5. 5. Immunology of Infectious Diseases Research Center, Research Institute of Basic Medical Sciences, Rafsanjan University of Medical Sciences, Rafsanjan, Iran
  6. 6. Department of Radiopharmacy, Faculty of Pharmacy, Tehran University of Medical Sciences, Tehran, Iran

Source: Iranian Journal of Nuclear Medicine Published:2024


Abstract

Blood products including RBC, platelets and plasma are used for the treatment of different diseases, especially in cancer patients. Administration of these derivatives may be associated with a wide range of adverse effects. Transfusion-associated graft-versus-host disease (TA-GVHD) is a fatal complication resulting from blood transfusion. Currently, irradiation of blood products containing cells, which can be achieved using X-ray or gamma ray, represents an optimal approach to prevent TA-GVHD. To the best of our knowledge, this is the first systematic review to address studies conducted to evaluate the effects of gamma irradiation from different sources of 60Co and 137Cs on the laboratory quality of platelets (PCs) and red blood cell concentrates (RBCCs). The results of our review on pre-storage (day 0) gamma irradiation of platelet products (apheresis and PRP) for 7 days of follow-up showed that there was no significant difference between non-irradiated and pre-storage 137Cs-irradiated PCs. In addition, 60Co-irradiated PRP before storage also showed comparable results to their non-irradiated counterparts. Results of our retrospective study on pre-storage (day 0) gamma irradiation of red blood cell concentrates (RBCCs) products for 28 days of follow-up, demonstrated that the viability of CPDA-1-preserved RBCCs appears to be 14 days post-irradiation, while this period for SAGM-preserved RBCCs is up to 21 days. Preservation of irradiated red blood cells in mannitol-containing solutions reduces lipid peroxidation. Overall, the results if our study showed that irradiation time and storage conditions, including preparation methods, anticoagulant/additive solutions, filtration, and washing, affect the quality of transfused blood products. © 2024 The Authors.
Related Docs
View other Related Docs
1. Advances in Nanotechnology for Improving the Targeted Delivery and Activity of Amphotericin B (2011–2023): A Systematic Review, Nanotoxicology (2024)
2. Latest Findings on the Effects of Gold Nanoparticles on the Storage Quality of Blood Products (2011-2022) - a Narrative Review, Current Drug Delivery (2024)
3. A Review Study of the Use of Modified Chitosan As a New Approach to Increase the Preservation of Blood Products (Erythrocytes, Platelets, and Plasma Products): 2010-2022, Nanomedicine Journal (2023)
4. Pegylation, a Successful Strategy to Address the Storage and Instability Problems of Blood Products: Review 2011-2021, Current Pharmaceutical Biotechnology (2024)
5. The Introduction of Dendrimers As a New Approach to Improve the Performance and Quality of Various Blood Products (Platelets, Plasma and Erythrocytes): A 2010-2022 Review Study, Current Nanoscience (2023)
6. A Review Study on the Application of Polymeric-Based Nanoparticles As a Novel Approach for Enhancing the Stability of Albumins, Nanomedicine Journal (2022)
7. A Review of the Use of Metallic Nanoparticles As a Novel Approach for Overcoming the Stability Challenges of Blood Products: A Narrative Review From 2011-2021, Current Drug Delivery (2023)
8. Investigating Factors Affecting the Effectiveness of Gardasil 4, Cervarix, and Gardasil 9 Vaccines Considering the Who Regions in Females: A Systematic Review, Cancer Epidemiology (2025)
Experts (# of related papers)
View all Related Experts
Mehdi Shafee Ardestani (12)
Seyed Mahdi Rezayat Sorkhabadi (3)
Other Related Docs
9. Application of Non-Metal Nanoparticles, As a Novel Approach, for Improving the Stability of Blood Products: 2011–2021, Progress in Biomaterials (2022)
10. A Novel Nanoformulation for Reducing the Toxicity and Increasing the Efficacy of Betulinic Acid Using Anionic Linear Globular Dendrimer, Journal of Nanostructures (2021)
11. Comparative Analysis Between Four Model Nanoformulations of Amphotericin B-Chitosan, Amphotericin B-Dendrimer, Betulinic Acid-Chitosan and Betulinic Acid-Dendrimer for Treatment of Leishmania Major: Real-Time Pcr Assay Plus, International Journal of Nanomedicine (2019)
12. Effective Materials of Medicinal Plants for Leishmania Treatment in Vivo Environment, Journal of Medicinal Plants (2020)
13. A Review Study About the Effect of Chitosan Nanocarrier on Improving the Efficacy of Amphotericin B in the Treatment of Leishmania From 2010 to 2020, Current Drug Delivery (2021)
14. Therapeutic Application of Nanoparticles in Hepatitis Diseases: A Narrative Review (2011-2021), Current Pharmaceutical Biotechnology (2023)
15. A Review Study of the Influences of Dendrimer Nanoparticles on Stored Platelet in Order to Treat Patients (2001-2020), Current Nanoscience (2022)